Zura Bio Limited

General ticker "ZURA" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $404.8M (TTM average)

Zura Bio Limited follows the US Stock Market performance with the rate: 40.8%.

Estimated limits based on current volatility of 3.5%: low 3.54$, high 3.79$

Factors to consider:

  • Total employees count: 30 as of 2024
  • Price in estimated range
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [2.67$, 6.85$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.91$, 5.05$]

Financial Metrics affecting the ZURA estimates:

  • Positive: with PPE of -4.4 at the end of fiscal year the price was neutral
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of -0.03 > -0.60
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of 0 <= 0
  • Positive: Interest expense per share per price, % of 0 <= 0.01

Similar symbols

Short-term ZURA quotes

Long-term ZURA plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $0.00MM $0.00MM
Operating Expenses $55.19MM $75.25MM
Operating Income $-55.19MM $-75.25MM
Non-Operating Income $2.79MM $6.60MM
R&D Expense $24.40MM $42.08MM
Income(Loss) $-52.40MM $-68.65MM
Net Income(Loss)* $-52.40MM $-68.65MM
Stockholders Equity $146.81MM $101.54MM
Assets $179.53MM $113.95MM
Operating Cash Flow $-28.08MM $-64.81MM
Capital expenditure $0.07MM $0.11MM
Investing Cash Flow $-5.08MM $-0.11MM
Financing Cash Flow $109.84MM $-2.16MM
Earnings Per Share** $-0.70 $-0.73

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.